Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan
哈萨克斯坦三种新型全口服缩短疗程治疗利福平耐药或多重耐药结核病的安全性和有效性
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae305
Rashitov, Makhmujan; Franke, Molly F; Trevisi, Letizia; Bekbolatova, Gulzhanat; Shalimova, Julia; Eshmetov, Gafurzhan; Bektasov, Sagit; LaHood, Allison; Arlyapova, Nataliya; Osso, Elna; Yedilbayev, Askar; Korotych, Oleksandr; Ciobanu, Anisoara; Skrahina, Alena; Mitnick, Carole D; Seung, Kwonjune J; Algozhin, Yerkebulan; Rich, Michael L